Is Cencora, Inc. (COR) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 11.0% / 30% | 6.2% / 30% | 36.2% / 30% | 0.04% / 5% | ✗ NOT HALAL |
| DJIM | 11.0% / 33% | 6.2% / 33% | 36.2% / 33% | 0.04% / 5% | ✗ NOT HALAL |
| MSCI | 10.0% / 33% | 5.7% / 33% | 32.9% / 33% | 0.04% / 5% | ✓ HALAL |
| S&P | 11.0% / 33% | 6.2% / 33% | 36.2% / 33% | 0.04% / 5% | ✗ NOT HALAL |
| FTSE | 10.0% / 33% | 5.7% / 33% | 32.9% / 50% | 0.04% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 3.6% | |
| Operating Margin | 1.2% | |
| Net Margin | 0.5% | |
| Return on Equity (ROE) | 133.5% | |
| Return on Assets (ROA) | 3.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $3.9B |
| Free Cash Flow | $3.2B |
| Total Debt | $7.7B |
| Debt-to-Equity | 472.6 |
| Current Ratio | 0.9 |
| Total Assets | $76.6B |
Price & Trading
| Last Close | $318.03 |
| 50-Day MA | $351.94 |
| 200-Day MA | $325.75 |
| Avg Volume | 1.2M |
| Beta | 0.6 |
|
52-Week Range
$267.40
| |
About Cencora, Inc. (COR)
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Cencora, Inc. (COR) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Cencora, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Cencora, Inc.'s debt ratio?
Cencora, Inc.'s debt ratio is 11.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 10.0%.
What are Cencora, Inc.'s key financial metrics?
Cencora, Inc. has a market capitalization of $60.8B, trailing P/E ratio of 37.5, and revenue of $321.3B. The company maintains a gross margin of 3.6% and a net margin of 0.5%. Return on equity stands at 133.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.